SCHRODINGER INC (SDGR) Stock News
NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD
SDGR Latest News, Press Relases and Analysis
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 121.05% and 2.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: FLGT
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
Microsoft Corporation (MSFT): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential
We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]
Caterpillar Inc. (CAT): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential
We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Caterpillar Inc. (NYSE:CAT) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]
Is Boston Scientific Corp. (NYSE:BSX) the Best Stock Under $100 to Buy According to Hedge Funds?
We recently published a list of the 12 Best Stocks Under $100 to Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against other stocks under $100 to buy according to hedge funds. On April 21, Chris Davis of Davis Advisors appeared […]
Is Advanced Micro Devices Inc. (NASDAQ:AMD) the Best Stock Under $100 to Buy According to Hedge Funds?
We recently published a list of the 12 Best Stocks Under $100 to Buy According to Hedge Funds. In this article, we are going to take a look at where Advanced Micro Devices Inc. (NASDAQ:AMD) stands against other stocks under $100 to buy according to hedge funds. On April 21, Chris Davis of Davis Advisors […]
Schrödinger to Announce First Quarter 2025 Financial Results on May 7
3 No-Brainer Energy Stocks to Buy Right Now
Demand drivers such as artificial inteligence (AI) data centers, the onshoring of manufacturing, and the electrification of everything will power a 55% surge in electricity demand by 2040, according to some estimates. Given the continued concerns surrounding climate change, this power will need to come from cleaner sources, including renewables, natural gas, and nuclear. This forecast makes energy companies focused on supporting growing electricity demand look like no-brainer investments right now.
3 Momentum Stocks That Could Soar Post-Market Volatility
Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Schrödinger to Present Preclinical Data at AACR Annual Meeting
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results
Schrödinger to Participate in Upcoming Investor Conferences
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
AI Pharma: 2 Paths to AI-Powered Drug Investment
AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
